Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer-Reference-Cited by-同舟云学术

Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer

Published:2023-01 Issue:1 Volume:41 Page:124-138.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Teng Huajing,Wang Yan,Sui Xin,Fan Jiawen,Li Shuai,Lei Xiao,Shi Chen,Sun Wei,Song Maxiaowei,Wang Hongzhi,Dong Dezuo,Geng Jianhao,Zhang Yangzi,Zhu Xianggao,Cai Yong,Li Yongheng,Li Bo,Min Qingjie,Wang Weihu,Zhan Qimin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference75 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA. Cancer J. Clin.,2018

2. Advances and challenges in treatment of locally advanced rectal cancer;Smith;J. Clin. Oncol.,2015

3. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol.,2011

4. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03;Roh;J. Clin. Oncol.,2009

5. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J. Clin. Oncol.,2012

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gut microbiome and the brain;Current Opinion in Supportive & Palliative Care;2024-09-13

2. Neo-adjuvant radiation and intratumoral immunotherapy followed by surgery- NARIS trial for extremity soft tissue sarcoma;Future Oncology;2024-09-13

3. Advancements in the study of human metagenomic variations: implications for disease development and personalized medicine;SCIENTIA SINICA Vitae;2024-09-01

4. Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in Colorectal Cancer;Heliyon;2024-09

5. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28